![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/40 | (2006.01) |
C07D 207/09 | (2013.01) | ||
A61K 31/166 | (2006.01) | ||
A61P 25/18 | (2018.01) | ||
A61K 45/06 | (2006.01) | ||
A61K 31/166 | (2013.01) | ||
A61P 25/18 | (2006.01) | ||
A61K 45/06 | (2013.01) | ||
A61P 25/24 | (2006.01) | ||
A61K 31/40 | (2013.01) | ||
C07D 207/09 | (2006.01) |
(11) | Number of the document | 3544606 |
(13) | Kind of document | T |
(96) | European patent application number | 17873556.9 |
Date of filing the European patent application | 2017-11-28 | |
(97) | Date of publication of the European application | 2019-10-02 |
(45) | Date of publication and mention of the grant of the patent | 2022-03-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/063529 |
Date | 2017-11-28 |
(87) | Number | WO 2018/098497 |
Date | 2018-05-31 |
(30) | Number | Date | Country code |
201662427062 P | 2016-11-28 | US | |
201762508263 P | 2017-05-18 | US |
(72) |
VAINO, Andrew R. , US
GRATTAN, Vincent T. , US
PRENSKY, Zachary , US
|
(73) |
LB Pharmaceuticals Inc. ,
575 Madison Avenue
Floor 10, New York, New York 10022,
US
|
(54) | PSYCHOTROPIC AGENTS AND USES THEREOF |
PSYCHOTROPIC AGENTS AND USES THEREOF |